Armenia vs Egypt: Cause of death, by non-communicable diseases, ages 5-14, male
Armenia
43.3%
in 2021
Egypt
43.6%
in 2021
Armenia rank
65th
Egypt rank
63rd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Armenia
- Egypt
How they compare
Egypt currently reports 43.6% against 43.3% in Armenia, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Armenia ahead.
Armenia ranks 65th and Egypt ranks 63rd of 185 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Egypt in 1.
Head to head by decade
| Decade | Armenia | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.6% | 42.3% | 0.3% | Armenia |
| 2010s | 51.3% | 45.7% | 5.6% | Armenia |
| 2020s | 23.7% | 44.8% | 21.0% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Armenia or Egypt?
- Egypt, at 43.6% against 43.3% in Armenia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Armenia and Egypt?
- 0.3%, with Egypt ahead.
- How many years of comparable data are there for Armenia and Egypt?
- 6 years are reported by both, from 2000 to 2021.
- How do Armenia and Egypt rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Armenia ranks 65th and Egypt ranks 63rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.